BACKGROUND AND PURPOSE: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. METHODS: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. RESULTS: Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r=0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P=0.448). CONCLUSIONS: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.
BACKGROUND AND PURPOSE: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. METHODS: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. RESULTS:Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r=0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P=0.448). CONCLUSIONS: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.
Authors: P D Schellinger; O Jansen; J B Fiebach; S Heiland; T Steiner; S Schwab; O Pohlers; H Ryssel; K Sartor; W Hacke Journal: Stroke Date: 2000-06 Impact factor: 7.914
Authors: Steven Warach; David Kaufman; David Chiu; Thomas Devlin; Marie Luby; Ajaz Rashid; Linda Clayton; Markku Kaste; Kennedy R Lees; Ralph Sacco; Marc Fisher Journal: Cerebrovasc Dis Date: 2005-12-09 Impact factor: 2.762
Authors: Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke Journal: Stroke Date: 2006-03-30 Impact factor: 7.914
Authors: S Warach; L C Pettigrew; J F Dashe; P Pullicino; D M Lefkowitz; L Sabounjian; K Harnett; U Schwiderski; R Gammans Journal: Ann Neurol Date: 2000-11 Impact factor: 10.422
Authors: Raquel Delgado-Mederos; Alex Rovira; José Alvarez-Sabín; Marc Ribó; Josep Munuera; Marta Rubiera; Esteban Santamarina; Olga Maisterra; Pilar Delgado; Joan Montaner; Carlos A Molina Journal: Stroke Date: 2007-02-08 Impact factor: 7.914
Authors: Hongyu An; Andria L Ford; Yasheng Chen; Hongtu Zhu; Rosana Ponisio; Gyanendra Kumar; Amirali Modir Shanechi; Naim Khoury; Katie D Vo; Jennifer Williams; Colin P Derdeyn; Michael N Diringer; Peter Panagos; William J Powers; Jin-Moo Lee; Weili Lin Journal: Stroke Date: 2015-02-26 Impact factor: 7.914
Authors: Aaryani Tipirneni-Sajja; Soren Christensen; Matus Straka; Manabu Inoue; Maarten G Lansberg; Michael Mlynash; Roland Bammer; Mark W Parsons; Geoffrey A Donnan; Stephen M Davis; Gregory W Albers Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Bruce C V Campbell; Archana Purushotham; Soren Christensen; Patricia M Desmond; Yoshinari Nagakane; Mark W Parsons; Maarten G Lansberg; Michael Mlynash; Matus Straka; Deidre A De Silva; Jean-Marc Olivot; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis Journal: J Cereb Blood Flow Metab Date: 2011-07-20 Impact factor: 6.200
Authors: Reyna L VanGilder; Danielle M Davidov; Kyle R Stinehart; Jason D Huber; Ryan C Turner; Karen S Wilson; Eric Haney; Stephen M Davis; Paul D Chantler; Laurie Theeke; Charles L Rosen; Todd J Crocco; Laurie Gutmann; Taura L Barr Journal: J Clin Neurosci Date: 2013-08-23 Impact factor: 1.961
Authors: Maija E Rossi; Eeva Jason; Silvia Marchesotti; Prasun Dastidar; Jyrki Ollikainen; Seppo Soimakallio Journal: BMC Med Imaging Date: 2010-09-17 Impact factor: 1.930